Global Relapsed Acute Myeloid Leukemia Drug Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

Jul 12, 2020 | 168 PAGES | REPORT CODE: CMM351830

REPORT SUMMARY
TABLE OF CONTENTS
INDUSTRY COVERAGE

The Relapsed Acute Myeloid Leukemia Drug is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 4.1% during the forecast period. The research provides insights for the global Relapsed Acute Myeloid Leukemia Drug market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Relapsed Acute Myeloid Leukemia Drug industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global Relapsed Acute Myeloid Leukemia Drug Market Segmentations:

By Players:

4SC AG
AbbVie Inc
Actinium Pharmaceuticals, Inc
Agios Pharmaceuticals, Inc
Amgen Inc
Arog Pharmaceuticals, Inc
Array BioPharma Inc
Astellas Pharma Inc
Astex Pharmaceuticals, Inc
AstraZeneca Plc
AVEO Pharmaceuticals, Inc
BioLineRx, Ltd
Boehringer Ingelheim GmbH
Boston Biomedical, Inc
Bristol-Myers Squibb Company
Calithera Biosciences, Inc
Celgene Corporation
Cornerstone Pharmaceuticals, Inc
CTI BioPharma Corp

By Types:

aNK Program
AT-9283
BI-836858
binimetinib
BL-8040
Others

By End-User:

Clinic
Hospital
Others

By Regions:

North America

United States
Canada
Mexico

Europe

Germany
UK
France
Italy
Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)
Spain
Belgium
Poland
Russia
Turkey
Others

Asia-Pacific

China
Japan
India
South Korea
Australia and New Zealand
ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)
Brazil
Nigeria
South Africa
Argentina
Others

Table of Contents

1 Report Overview

1.1 Product Definition and Scope
1.2 PEST (Political, Economic, Social and Technological) Analysis of Relapsed Acute Myeloid Leukemia Drug Market
1.3 Market Segmentation by Type

1.3.1 Global Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate of aNK Program from 2014 to 2026
1.3.2 Global Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate of AT-9283 from 2014 to 2026
1.3.3 Global Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate of BI-836858 from 2014 to 2026
1.3.4 Global Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate of binimetinib from 2014 to 2026
1.3.5 Global Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate of BL-8040 from 2014 to 2026
1.3.6 Global Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate of Others from 2014 to 2026

1.4 Market Segmentation by End-Users

1.4.1 Global Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate of Clinic from 2014 to 2026
1.4.2 Global Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate of Hospital from 2014 to 2026
1.4.3 Global Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate of Others from 2014 to 2026

1.5 Market Segmentation by Regions

1.5.1 North America Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate from 2014 to 2026

1.5.1.1 United States Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate from 2014 to 2026
1.5.1.2 Canada Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate from 2014 to 2026
1.5.1.3 Mexico Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate from 2014 to 2026

1.5.2 Europe Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate from 2014 to 2026

1.5.2.1 Germany Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate from 2014 to 2026
1.5.2.2 UK Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate from 2014 to 2026
1.5.2.3 France Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate from 2014 to 2026
1.5.2.4 Italy Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate from 2014 to 2026
1.5.2.5 Nordic Countries Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate from 2014 to 2026
1.5.2.6 Spain Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate from 2014 to 2026
1.5.2.7 Belgium Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate from 2014 to 2026
1.5.2.8 Poland Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate from 2014 to 2026
1.5.2.9 Russia Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate from 2014 to 2026
1.5.2.10 Turkey Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate from 2014 to 2026

1.5.3 Asia-Pacific Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate from 2014 to 2026

1.5.3.1 China Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate from 2014 to 2026
1.5.3.2 Japan Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate from 2014 to 2026
1.5.3.3 Australia and New Zealand Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate from 2014 to 2026
1.5.3.4 India Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate from 2014 to 2026
1.5.3.5 ASEAN Countries Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate from 2014 to 2026
1.5.3.6 South Korea Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate from 2014 to 2026

1.5.4 Latin America, Middle East & Africa Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate from 2014 to 2026

1.5.4.1 GCC Countries Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate from 2014 to 2026
1.5.4.2 Brazil Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate from 2014 to 2026
1.5.4.3 Nigeria Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate from 2014 to 2026
1.5.4.4 South Africa Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate from 2014 to 2026
1.5.4.5 Argentina Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

2.1 Market Trends and Dynamics

2.1.1 Market Challenges and Restraints
2.1.2 Market Opportunities and Potentials
2.1.3 Mergers and Acquisitions

2.2 Competitive Landscape Analysis

2.2.1 Industrial Concentration Analysis
2.2.2 Porter's Five Forces Analysis of the Industry
2.2.3 SWOT Analysis for New Entrants

3 Segmentation of Relapsed Acute Myeloid Leukemia Drug Market by Types

3.1 Product Development Trends of Different Types
3.2 Commercial Product Types of Major Vendors
3.3 Competitive Landscape Analysis of Different Types
3.4 Market Size of Relapsed Acute Myeloid Leukemia Drug by Major Types

3.4.1 Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate of aNK Program
3.4.2 Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate of AT-9283
3.4.3 Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate of BI-836858
3.4.4 Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate of binimetinib
3.4.5 Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate of BL-8040
3.4.6 Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate of Others

4 Segmentation of Relapsed Acute Myeloid Leukemia Drug Market by End-Users

4.1 Downstream Client Analysis by End-Users
4.2 Competitive Landscape Analysis of Different End-Users
4.3 Market Potential Analysis of Different End-Users
4.4 Market Size of Relapsed Acute Myeloid Leukemia Drug by Major End-Users

4.4.1 Market Size and Growth Rate of Relapsed Acute Myeloid Leukemia Drug in Clinic
4.4.2 Market Size and Growth Rate of Relapsed Acute Myeloid Leukemia Drug in Hospital
4.4.3 Market Size and Growth Rate of Relapsed Acute Myeloid Leukemia Drug in Others

5 Market Analysis by Major Regions

5.1 Global Relapsed Acute Myeloid Leukemia Drug Production Analysis by Major Regions
5.2 Global Relapsed Acute Myeloid Leukemia Drug Consumption Analysis by Major Regions
5.3 Global Relapsed Acute Myeloid Leukemia Drug Production, Import, Consumption and Export Analysis by Regions

5.3.1 North America Relapsed Acute Myeloid Leukemia Drug Production, Import, Consumption and Export Analysis
5.3.2 Europe Relapsed Acute Myeloid Leukemia Drug Production, Import, Consumption and Export Analysis
5.3.3 Asia Pacific Relapsed Acute Myeloid Leukemia Drug Production, Import, Consumption and Export Analysis
5.3.4 Latin America, Middle East & Africa Relapsed Acute Myeloid Leukemia Drug Production, Import, Consumption and Export Analysis

6 Product Commodity of Relapsed Acute Myeloid Leukemia Drug Market in Major Countries

6.1 Top 5 Export Countries in Relapsed Acute Myeloid Leukemia Drug market from 2014 to 2019

6.1.1 Top 5 Export Countries' Export Value Analysis in Relapsed Acute Myeloid Leukemia Drug market from 2014 to 2019
6.1.2 Top 5 Export Countries' Export Volume Analysis in Relapsed Acute Myeloid Leukemia Drug market from 2014 to 2019

6.2 Top 5 Import Countries in Relapsed Acute Myeloid Leukemia Drug market from 2014 to 2019

6.2.1 Top 5 Import Countries' Import Value Analysis in Relapsed Acute Myeloid Leukemia Drug market from 2014 to 2019
6.2.2 Top 5 Import Countries' Import Volume Analysis in Relapsed Acute Myeloid Leukemia Drug market from 2014 to 2019

6.3 Emerging Top 3 Export Countries Analysis
6.4 Emerging Top 3 Import Countries Analysis

7 North America Relapsed Acute Myeloid Leukemia Drug Landscape Analysis

7.1 North America Relapsed Acute Myeloid Leukemia Drug Landscape Analysis by Major Types
7.2 North America Relapsed Acute Myeloid Leukemia Drug Landscape Analysis by Major End-Users
7.3 North America Relapsed Acute Myeloid Leukemia Drug Landscape Analysis by Major Countries

7.3.1 United States Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate
7.3.2 Canada Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate
7.3.3 Mexico Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate

8 Europe Relapsed Acute Myeloid Leukemia Drug Landscape Analysis

8.1 Europe Relapsed Acute Myeloid Leukemia Drug Landscape Analysis by Major Types
8.2 Europe Relapsed Acute Myeloid Leukemia Drug Landscape Analysis by Major End-Users
8.3 Europe Relapsed Acute Myeloid Leukemia Drug Landscape Analysis by Major Countries

8.3.1 Germany Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate
8.3.2 UK Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate
8.3.3 France Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate
8.3.4 Italy Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate
8.3.5 Nordic Countries Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate
8.3.6 Spain Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate
8.3.7 Belgium Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate
8.3.8 Poland Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate
8.3.9 Russia Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate
8.3.10 Turkey Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate

9 Asia Pacific Relapsed Acute Myeloid Leukemia Drug Landscape Analysis

9.1 Asia Pacific Relapsed Acute Myeloid Leukemia Drug Landscape Analysis by Major Types
9.2 Asia Pacific Relapsed Acute Myeloid Leukemia Drug Landscape Analysis by Major End-Users
9.3 Asia Pacific Relapsed Acute Myeloid Leukemia Drug Landscape Analysis by Major Countries

9.3.1 China Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate
9.3.2 Japan Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate
9.3.3 Australia and New Zealand Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate
9.3.4 India Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate
9.3.5 ASEAN Countries Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate
9.3.6 South Korea Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate

10 Latin America, Middle East & Africa Relapsed Acute Myeloid Leukemia Drug Landscape Analysis

10.1 Latin America, Middle East & Africa Relapsed Acute Myeloid Leukemia Drug Landscape Analysis by Major Types
10.2 Latin America, Middle East & Africa Relapsed Acute Myeloid Leukemia Drug Landscape Analysis by Major End-Users
10.3 Latin America, Middle East & Africa Relapsed Acute Myeloid Leukemia Drug Landscape Analysis by Major Countries

10.3.1 GCC Countries Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate
10.3.2 Brazil Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate
10.3.3 Nigeria Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate
10.3.4 South Africa Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate
10.3.5 Argentina Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate

11 Major Players Profile

11.1 4SC AG

11.1.1 4SC AG Company Profile and Recent Development
11.1.2 Market Performance
11.1.3 Product and Service Introduction

11.2 AbbVie Inc

11.2.1 AbbVie Inc Company Profile and Recent Development
11.2.2 Market Performance
11.2.3 Product and Service Introduction

11.3 Actinium Pharmaceuticals, Inc

11.3.1 Actinium Pharmaceuticals, Inc Company Profile and Recent Development
11.3.2 Market Performance
11.3.3 Product and Service Introduction

11.4 Agios Pharmaceuticals, Inc

11.4.1 Agios Pharmaceuticals, Inc Company Profile and Recent Development
11.4.2 Market Performance
11.4.3 Product and Service Introduction

11.5 Amgen Inc

11.5.1 Amgen Inc Company Profile and Recent Development
11.5.2 Market Performance
11.5.3 Product and Service Introduction

11.6 Arog Pharmaceuticals, Inc

11.6.1 Arog Pharmaceuticals, Inc Company Profile and Recent Development
11.6.2 Market Performance
11.6.3 Product and Service Introduction

11.7 Array BioPharma Inc

11.7.1 Array BioPharma Inc Company Profile and Recent Development
11.7.2 Market Performance
11.7.3 Product and Service Introduction

11.8 Astellas Pharma Inc

11.8.1 Astellas Pharma Inc Company Profile and Recent Development
11.8.2 Market Performance
11.8.3 Product and Service Introduction

11.9 Astex Pharmaceuticals, Inc

11.9.1 Astex Pharmaceuticals, Inc Company Profile and Recent Development
11.9.2 Market Performance
11.9.3 Product and Service Introduction

11.10 AstraZeneca Plc

11.10.1 AstraZeneca Plc Company Profile and Recent Development
11.10.2 Market Performance
11.10.3 Product and Service Introduction

11.11 AVEO Pharmaceuticals, Inc

11.11.1 AVEO Pharmaceuticals, Inc Company Profile and Recent Development
11.11.2 Market Performance
11.11.3 Product and Service Introduction

11.12 BioLineRx, Ltd

11.12.1 BioLineRx, Ltd Company Profile and Recent Development
11.12.2 Market Performance
11.12.3 Product and Service Introduction

11.13 Boehringer Ingelheim GmbH

11.13.1 Boehringer Ingelheim GmbH Company Profile and Recent Development
11.13.2 Market Performance
11.13.3 Product and Service Introduction

11.14 Boston Biomedical, Inc

11.14.1 Boston Biomedical, Inc Company Profile and Recent Development
11.14.2 Market Performance
11.14.3 Product and Service Introduction

11.15 Bristol-Myers Squibb Company

11.15.1 Bristol-Myers Squibb Company Company Profile and Recent Development
11.15.2 Market Performance
11.15.3 Product and Service Introduction

11.16 Calithera Biosciences, Inc

11.16.1 Calithera Biosciences, Inc Company Profile and Recent Development
11.16.2 Market Performance
11.16.3 Product and Service Introduction

11.17 Celgene Corporation

11.17.1 Celgene Corporation Company Profile and Recent Development
11.17.2 Market Performance
11.17.3 Product and Service Introduction

11.18 Cornerstone Pharmaceuticals, Inc

11.18.1 Cornerstone Pharmaceuticals, Inc Company Profile and Recent Development
11.18.2 Market Performance
11.18.3 Product and Service Introduction

11.19 CTI BioPharma Corp

11.19.1 CTI BioPharma Corp Company Profile and Recent Development
11.19.2 Market Performance
11.19.3 Product and Service Introduction

12 Data Source and Research Methodology

The List of Tables and Figures (Totals 122 Figures and 193 Tables)

Figure Product Picture
Figure Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate of aNK Program from 2014 to 2026
Figure Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate of AT-9283 from 2014 to 2026
Figure Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate of BI-836858 from 2014 to 2026
Figure Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate of binimetinib from 2014 to 2026
Figure Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate of BL-8040 from 2014 to 2026
Figure Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate of Others from 2014 to 2026
Figure Market Share by Type in 2014
Figure Market Share by Type in 2018
Figure Market Share by Type in 2026
Figure Global Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate of Clinic from 2014 to 2026
Figure Global Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate of Hospital from 2014 to 2026
Figure Global Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate of Others from 2014 to 2026
Figure Market Share by End-User in 2014
Figure Market Share by End-User in 2018
Figure Market Share by End-User in 2026
Figure North America Relapsed Acute Myeloid Leukemia Drug Consumption Market Size and Growth Rate from 2014 to 2026
Figure United States Relapsed Acute Myeloid Leukemia Drug Consumption Market Size and Growth Rate from 2014 to 2026
Figure Canada Relapsed Acute Myeloid Leukemia Drug Consumption Market Size and Growth Rate from 2014 to 2026
Figure Mexico Relapsed Acute Myeloid Leukemia Drug Consumption Market Size and Growth Rate from 2014 to 2026
Figure Europe Relapsed Acute Myeloid Leukemia Drug Consumption Market Size and Growth Rate from 2014 to 2026
Figure Germany Relapsed Acute Myeloid Leukemia Drug Consumption Market Size and Growth Rate from 2014 to 2026
Figure UK Relapsed Acute Myeloid Leukemia Drug Consumption Market Size and Growth Rate from 2014 to 2026
Figure France Relapsed Acute Myeloid Leukemia Drug Consumption Market Size and Growth Rate from 2014 to 2026
Figure Italy Relapsed Acute Myeloid Leukemia Drug Consumption Market Size and Growth Rate from 2014 to 2026
Figure Nordic Countries Relapsed Acute Myeloid Leukemia Drug Consumption Market Size and Growth Rate from 2014 to 2026
Figure Spain Relapsed Acute Myeloid Leukemia Drug Consumption Market Size and Growth Rate from 2014 to 2026
Figure Belgium Relapsed Acute Myeloid Leukemia Drug Consumption Market Size and Growth Rate from 2014 to 2026
Figure Poland Relapsed Acute Myeloid Leukemia Drug Consumption Market Size and Growth Rate from 2014 to 2026
Figure Russia Relapsed Acute Myeloid Leukemia Drug Consumption Market Size and Growth Rate from 2014 to 2026
Figure Turkey Relapsed Acute Myeloid Leukemia Drug Consumption Market Size and Growth Rate from 2014 to 2026
Figure Asia-Pacific Relapsed Acute Myeloid Leukemia Drug Consumption Market Size and Growth Rate from 2014 to 2026
Figure China Relapsed Acute Myeloid Leukemia Drug Consumption Market Size and Growth Rate from 2014 to 2026
Figure Japan Relapsed Acute Myeloid Leukemia Drug Consumption Market Size and Growth Rate from 2014 to 2026
Figure Australia and New Zealand Relapsed Acute Myeloid Leukemia Drug Consumption Market Size and Growth Rate from 2014 to 2026
Figure India Relapsed Acute Myeloid Leukemia Drug Consumption Market Size and Growth Rate from 2014 to 2026
Figure ASEAN Countries Relapsed Acute Myeloid Leukemia Drug Consumption Market Size and Growth Rate from 2014 to 2026
Figure South Korea Relapsed Acute Myeloid Leukemia Drug Consumption Market Size and Growth Rate from 2014 to 2026
Figure Latin America, Middle East & Africa Relapsed Acute Myeloid Leukemia Drug Consumption Market Size and Growth Rate from 2014 to 2026
Figure GCC Countries Relapsed Acute Myeloid Leukemia Drug Consumption Market Size and Growth Rate from 2014 to 2026
Figure Brazil Relapsed Acute Myeloid Leukemia Drug Consumption Market Size and Growth Rate from 2014 to 2026
Figure Nigeria Relapsed Acute Myeloid Leukemia Drug Consumption Market Size and Growth Rate from 2014 to 2026
Figure South Africa Relapsed Acute Myeloid Leukemia Drug Consumption Market Size and Growth Rate from 2014 to 2026
Figure Argentina Relapsed Acute Myeloid Leukemia Drug Consumption Market Size and Growth Rate from 2014 to 2026
Figure Development Trends and Industry Dynamics of Relapsed Acute Myeloid Leukemia Drug Industry
Figure Market Challenges and Restraints
Figure Market Opportunities and Potentials
Table Mergers and Acquisition
Figure Market Share of TOP 3 Players in 2018
Figure Market Share of TOP 5 Players in 2018
Figure Market Share of TOP 6 Players from 2014 to 2019
Figure Porter's Five Forces Analysis
Figure New Entrant SWOT Analysis
Table Specifications of Different Types of Relapsed Acute Myeloid Leukemia Drug
Figure Development Trends of Different Types
Table Commercial Products Types of Major Vendors
Figure Competitive Landscape Analysis of Different Types
Table Consumption of Relapsed Acute Myeloid Leukemia Drug by Different Types from 2014 to 2026
Table Consumption Share of Relapsed Acute Myeloid Leukemia Drug by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of aNK Program
Figure Market Size and Growth Rate of AT-9283
Figure Market Size and Growth Rate of BI-836858
Figure Market Size and Growth Rate of binimetinib
Figure Market Size and Growth Rate of BL-8040
Figure Market Size and Growth Rate of Others
Table Downstream Client Analysis by End-Users
Figure Competitive Landscape Analysis of Different End-Users
Table Market Potential Analysis of Different End-Users
Table Consumption of Relapsed Acute Myeloid Leukemia Drug by Different End-Users from 2014 to 2026
Table Consumption Share of Relapsed Acute Myeloid Leukemia Drug by Different End-Users from 2014 to 2026
Figure Market Size and Growth Rate of Clinic
Figure Market Size and Growth Rate of Hospital
Figure Market Size and Growth Rate of Others
Table Global Relapsed Acute Myeloid Leukemia Drug Production by Major Regions
Table Global Relapsed Acute Myeloid Leukemia Drug Production Share by Major Regions
Figure Global Relapsed Acute Myeloid Leukemia Drug Production Share by Major Regions in 2014
Figure Global Relapsed Acute Myeloid Leukemia Drug Production Share by Major Regions in 2018
Figure Global Relapsed Acute Myeloid Leukemia Drug Production Share by Major Regions in 2026
Table Global Relapsed Acute Myeloid Leukemia Drug Consumption by Major Regions
Table Global Relapsed Acute Myeloid Leukemia Drug Consumption Share by Major Regions
Figure Global Relapsed Acute Myeloid Leukemia Drug Consumption Share by Major Regions in 2014
Figure Global Relapsed Acute Myeloid Leukemia Drug Consumption Share by Major Regions in 2018
Figure Global Relapsed Acute Myeloid Leukemia Drug Consumption Share by Major Regions in 2026
Table North America Relapsed Acute Myeloid Leukemia Drug Production, Import, Consumption and Export Analysis
Table Europe Relapsed Acute Myeloid Leukemia Drug Production, Import, Consumption and Export Analysis
Table Asia Pacific Relapsed Acute Myeloid Leukemia Drug Production, Import, Consumption and Export Analysis
Table Latin America, Middle East & Africa Relapsed Acute Myeloid Leukemia Drug Production, Import, Consumption and Export Analysis
Table Top 5 Export Countries' Export Value Analysis in Relapsed Acute Myeloid Leukemia Drug market from 2014 to 2019
Table Top 5 Export Countries' Export Volume Analysis in Relapsed Acute Myeloid Leukemia Drug market from 2014 to 2019
Table Top 5 Import Countries' Import Value Analysis in Relapsed Acute Myeloid Leukemia Drug market from 2014 to 2019
Table Top 5 Import Countries' Import Volume Analysis in Relapsed Acute Myeloid Leukemia Drug market from 2014 to 2019
Figure Emerging Top 3 Export Countries Analysis
Figure Emerging Top 3 Import Countries Analysis
Table North America Relapsed Acute Myeloid Leukemia Drug Consumption by Types from 2014 to 2026
Table North America Relapsed Acute Myeloid Leukemia Drug Consumption Share by Types from 2014 to 2026
Figure North America Relapsed Acute Myeloid Leukemia Drug Consumption Share by Types in 2014
Figure North America Relapsed Acute Myeloid Leukemia Drug Consumption Share by Types in 2018
Figure North America Relapsed Acute Myeloid Leukemia Drug Consumption Share by Types in 2026
Table North America Relapsed Acute Myeloid Leukemia Drug Consumption by End-Users from 2014 to 2026
Table North America Relapsed Acute Myeloid Leukemia Drug Consumption Share by End-Users from 2014 to 2026
Figure North America Relapsed Acute Myeloid Leukemia Drug Consumption Share by End-Users in 2014
Figure North America Relapsed Acute Myeloid Leukemia Drug Consumption Share by End-Users in 2018
Figure North America Relapsed Acute Myeloid Leukemia Drug Consumption Share by End-Users in 2026
Table North America Relapsed Acute Myeloid Leukemia Drug Consumption by Major Countries from 2014 to 2026
Table North America Relapsed Acute Myeloid Leukemia Drug Consumption Share by Major Countries from 2014 to 2026
Figure North America Relapsed Acute Myeloid Leukemia Drug Consumption Share by Major Countries in 2014
Figure North America Relapsed Acute Myeloid Leukemia Drug Consumption Share by Major Countries in 2018
Figure North America Relapsed Acute Myeloid Leukemia Drug Consumption Share by Major Countries in 2026
Figure United States Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate from 2014 to 2026
Figure Canada Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate from 2014 to 2026
Figure Mexico Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate from 2014 to 2026
Table Europe Relapsed Acute Myeloid Leukemia Drug Consumption by Types from 2014 to 2026
Table Europe Relapsed Acute Myeloid Leukemia Drug Consumption Share by Types from 2014 to 2026
Figure Europe Relapsed Acute Myeloid Leukemia Drug Consumption Share by Types in 2014
Figure Europe Relapsed Acute Myeloid Leukemia Drug Consumption Share by Types in 2018
Figure Europe Relapsed Acute Myeloid Leukemia Drug Consumption Share by Types in 2026
Table Europe Relapsed Acute Myeloid Leukemia Drug Consumption by End-Users from 2014 to 2026
Table Europe Relapsed Acute Myeloid Leukemia Drug Consumption Share by End-Users from 2014 to 2026
Figure Europe Relapsed Acute Myeloid Leukemia Drug Consumption Share by End-Users in 2014
Figure Europe Relapsed Acute Myeloid Leukemia Drug Consumption Share by End-Users in 2018
Figure Europe Relapsed Acute Myeloid Leukemia Drug Consumption Share by End-Users in 2026
Table Europe Relapsed Acute Myeloid Leukemia Drug Consumption by Major Countries from 2014 to 2026
Table Europe Relapsed Acute Myeloid Leukemia Drug Consumption Share by Major Countries from 2014 to 2026
Figure Europe Relapsed Acute Myeloid Leukemia Drug Consumption Share by Major Countries in 2014
Figure Europe Relapsed Acute Myeloid Leukemia Drug Consumption Share by Major Countries in 2018
Figure Europe Relapsed Acute Myeloid Leukemia Drug Consumption Share by Major Countries in 2026
Figure Germany Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate from 2014 to 2026
Figure UK Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate from 2014 to 2026
Figure France Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate from 2014 to 2026
Figure Italy Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate from 2014 to 2026
Figure Nordic Countries Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate from 2014 to 2026
Figure Belgium Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate from 2014 to 2026
Figure Poland Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate from 2014 to 2026
Figure Russia Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate from 2014 to 2026
Figure Turkey Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate from 2014 to 2026
Table Asia Pacific Relapsed Acute Myeloid Leukemia Drug Consumption by Types from 2014 to 2026
Table Asia Pacific Relapsed Acute Myeloid Leukemia Drug Consumption Share by Types from 2014 to 2026
Figure Asia Pacific Relapsed Acute Myeloid Leukemia Drug Consumption Share by Types in 2014
Figure Asia Pacific Relapsed Acute Myeloid Leukemia Drug Consumption Share by Types in 2018
Figure Asia Pacific Relapsed Acute Myeloid Leukemia Drug Consumption Share by Types in 2026
Table Asia Pacific Relapsed Acute Myeloid Leukemia Drug Consumption by End-Users from 2014 to 2026
Table Asia Pacific Relapsed Acute Myeloid Leukemia Drug Consumption Share by End-Users from 2014 to 2026
Figure Asia Pacific Relapsed Acute Myeloid Leukemia Drug Consumption Share by End-Users in 2014
Figure Asia Pacific Relapsed Acute Myeloid Leukemia Drug Consumption Share by End-Users in 2018
Figure Asia Pacific Relapsed Acute Myeloid Leukemia Drug Consumption Share by End-Users in 2026
Table Asia Pacific Relapsed Acute Myeloid Leukemia Drug Consumption by Major Countries from 2014 to 2026
Table Asia Pacific Relapsed Acute Myeloid Leukemia Drug Consumption Share by Major Countries from 2014 to 2026
Figure Asia Pacific Relapsed Acute Myeloid Leukemia Drug Consumption Share by Major Countries in 2014
Figure Asia Pacific Relapsed Acute Myeloid Leukemia Drug Consumption Share by Major Countries in 2018
Figure Asia Pacific Relapsed Acute Myeloid Leukemia Drug Consumption Share by Major Countries in 2026
Figure China Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate from 2014 to 2026
Figure Japan Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate from 2014 to 2026
Figure Australia and New ZealandRelapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate from 2014 to 2026
Figure India Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate from 2014 to 2026
Figure ASEAN Countries Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate from 2014 to 2026
Figure South Korea Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate from 2014 to 2026
Table Latin America, Middle East & Africa Relapsed Acute Myeloid Leukemia Drug Consumption by Types from 2014 to 2026
Table Latin America, Middle East & Africa Relapsed Acute Myeloid Leukemia Drug Consumption Share by Types from 2014 to 2026
Figure Latin America, Middle East & Africa Relapsed Acute Myeloid Leukemia Drug Consumption Share by Types in 2014
Figure Latin America, Middle East & Africa Relapsed Acute Myeloid Leukemia Drug Consumption Share by Types in 2018
Figure Latin America, Middle East & Africa Relapsed Acute Myeloid Leukemia Drug Consumption Share by Types in 2026
Table Latin America, Middle East & Africa Relapsed Acute Myeloid Leukemia Drug Consumption by End-Users from 2014 to 2026
Table Latin America, Middle East & Africa Relapsed Acute Myeloid Leukemia Drug Consumption Share by End-Users from 2014 to 2026
Figure Latin America, Middle East & Africa Relapsed Acute Myeloid Leukemia Drug Consumption Share by End-Users in 2014
Figure Latin America, Middle East & Africa Relapsed Acute Myeloid Leukemia Drug Consumption Share by End-Users in 2018
Figure Latin America, Middle East & Africa Relapsed Acute Myeloid Leukemia Drug Consumption Share by End-Users in 2026
Table Latin America, Middle East & Africa Relapsed Acute Myeloid Leukemia Drug Consumption by Major Countries from 2014 to 2026
Table Latin America, Middle East & Africa Relapsed Acute Myeloid Leukemia Drug Consumption Share by Major Countries from 2014 to 2026
Figure Latin America, Middle East & Africa Relapsed Acute Myeloid Leukemia Drug Consumption Share by Major Countries in 2014
Figure Latin America, Middle East & Africa Relapsed Acute Myeloid Leukemia Drug Consumption Share by Major Countries in 2018
Figure Latin America, Middle East & Africa Relapsed Acute Myeloid Leukemia Drug Consumption Share by Major Countries in 2026
Figure GCC Countries Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate from 2014 to 2026
Figure Brazil Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate from 2014 to 2026
Figure Nigeria Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate from 2014 to 2026
Figure South Africa Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate from 2014 to 2026
Figure Argentina Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate from 2014 to 2026
Table Company Profile and Development Status of 4SC AG
Table Sales, Revenue, Sales Price and Gross Margin Analysis of 4SC AG
Figure Sales and Growth Rate Analysis of 4SC AG
Figure Revenue and Market Share Analysis of 4SC AG
Table Product and Service Introduction of 4SC AG
Table Company Profile and Development Status of AbbVie Inc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie Inc
Figure Sales and Growth Rate Analysis of AbbVie Inc
Figure Revenue and Market Share Analysis of AbbVie Inc
Table Product and Service Introduction of AbbVie Inc
Table Company Profile and Development Status of Actinium Pharmaceuticals, Inc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Actinium Pharmaceuticals, Inc
Figure Sales and Growth Rate Analysis of Actinium Pharmaceuticals, Inc
Figure Revenue and Market Share Analysis of Actinium Pharmaceuticals, Inc
Table Product and Service Introduction of Actinium Pharmaceuticals, Inc
Table Company Profile and Development Status of Agios Pharmaceuticals, Inc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Agios Pharmaceuticals, Inc
Figure Sales and Growth Rate Analysis of Agios Pharmaceuticals, Inc
Figure Revenue and Market Share Analysis of Agios Pharmaceuticals, Inc
Table Product and Service Introduction of Agios Pharmaceuticals, Inc
Table Company Profile and Development Status of Amgen Inc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen Inc
Figure Sales and Growth Rate Analysis of Amgen Inc
Figure Revenue and Market Share Analysis of Amgen Inc
Table Product and Service Introduction of Amgen Inc
Table Company Profile and Development Status of Arog Pharmaceuticals, Inc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Arog Pharmaceuticals, Inc
Figure Sales and Growth Rate Analysis of Arog Pharmaceuticals, Inc
Figure Revenue and Market Share Analysis of Arog Pharmaceuticals, Inc
Table Product and Service Introduction of Arog Pharmaceuticals, Inc
Table Company Profile and Development Status of Array BioPharma Inc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Array BioPharma Inc
Figure Sales and Growth Rate Analysis of Array BioPharma Inc
Figure Revenue and Market Share Analysis of Array BioPharma Inc
Table Product and Service Introduction of Array BioPharma Inc
Table Company Profile and Development Status of Astellas Pharma Inc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma Inc
Figure Sales and Growth Rate Analysis of Astellas Pharma Inc
Figure Revenue and Market Share Analysis of Astellas Pharma Inc
Table Product and Service Introduction of Astellas Pharma Inc
Table Company Profile and Development Status of Astex Pharmaceuticals, Inc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astex Pharmaceuticals, Inc
Figure Sales and Growth Rate Analysis of Astex Pharmaceuticals, Inc
Figure Revenue and Market Share Analysis of Astex Pharmaceuticals, Inc
Table Product and Service Introduction of Astex Pharmaceuticals, Inc
Table Company Profile and Development Status of AstraZeneca Plc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca Plc
Figure Sales and Growth Rate Analysis of AstraZeneca Plc
Figure Revenue and Market Share Analysis of AstraZeneca Plc
Table Product and Service Introduction of AstraZeneca Plc
Table Company Profile and Development Status of AVEO Pharmaceuticals, Inc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AVEO Pharmaceuticals, Inc
Figure Sales and Growth Rate Analysis of AVEO Pharmaceuticals, Inc
Figure Revenue and Market Share Analysis of AVEO Pharmaceuticals, Inc
Table Product and Service Introduction of AVEO Pharmaceuticals, Inc
Table Company Profile and Development Status of BioLineRx, Ltd
Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioLineRx, Ltd
Figure Sales and Growth Rate Analysis of BioLineRx, Ltd
Figure Revenue and Market Share Analysis of BioLineRx, Ltd
Table Product and Service Introduction of BioLineRx, Ltd
Table Company Profile and Development Status of Boehringer Ingelheim GmbH
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim GmbH
Figure Sales and Growth Rate Analysis of Boehringer Ingelheim GmbH
Figure Revenue and Market Share Analysis of Boehringer Ingelheim GmbH
Table Product and Service Introduction of Boehringer Ingelheim GmbH
Table Company Profile and Development Status of Boston Biomedical, Inc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boston Biomedical, Inc
Figure Sales and Growth Rate Analysis of Boston Biomedical, Inc
Figure Revenue and Market Share Analysis of Boston Biomedical, Inc
Table Product and Service Introduction of Boston Biomedical, Inc
Table Company Profile and Development Status of Bristol-Myers Squibb Company
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb Company
Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb Company
Figure Revenue and Market Share Analysis of Bristol-Myers Squibb Company
Table Product and Service Introduction of Bristol-Myers Squibb Company
Table Company Profile and Development Status of Calithera Biosciences, Inc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Calithera Biosciences, Inc
Figure Sales and Growth Rate Analysis of Calithera Biosciences, Inc
Figure Revenue and Market Share Analysis of Calithera Biosciences, Inc
Table Product and Service Introduction of Calithera Biosciences, Inc
Table Company Profile and Development Status of Celgene Corporation
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene Corporation
Figure Sales and Growth Rate Analysis of Celgene Corporation
Figure Revenue and Market Share Analysis of Celgene Corporation
Table Product and Service Introduction of Celgene Corporation
Table Company Profile and Development Status of Cornerstone Pharmaceuticals, Inc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cornerstone Pharmaceuticals, Inc
Figure Sales and Growth Rate Analysis of Cornerstone Pharmaceuticals, Inc
Figure Revenue and Market Share Analysis of Cornerstone Pharmaceuticals, Inc
Table Product and Service Introduction of Cornerstone Pharmaceuticals, Inc
Table Company Profile and Development Status of CTI BioPharma Corp
Table Sales, Revenue, Sales Price and Gross Margin Analysis of CTI BioPharma Corp
Figure Sales and Growth Rate Analysis of CTI BioPharma Corp
Figure Revenue and Market Share Analysis of CTI BioPharma Corp
Table Product and Service Introduction of CTI BioPharma Corp

REPORTS

Let’s Pullulate and Expand Your Business